European Archives - European Medical Journal

Study Reveals Distinct Epigenetic Signatures in Diabetes

Researchers identified distinct DNA methylation signatures associated with ageing and type 2 diabetes in pancreatic islets, revealing potential biomarkers and therapeutic

Climate Change Could Triple Cardiovascular Disease Burden by 2050

Heat exposure may drive a threefold increase in cardiovascular disease burden across the USA by 2050, according to new projections.

Microbiome Maturation Influences Neurodevelopmental Disorder Risk

Researchers investigate how specific gut bacteria might modify the impact of perinatal epigenetic changes associated with neurodevelopmental disorders.

Brain Imaging Predicts Ketamine Response in Depression

Brain imaging combined with machine learning predicted ketamine response in patients with treatment-resistant depression, supporting more personalised care.

CAR-T Trial Access Lower for People With HIV

People living with HIV face significantly longer travel times and reduced access to CAR-T clinical trials for non-Hodgkin lymphoma, with disparities most pronounced in the southern United States.

Plant-Based Diet Reduces Mortality in CKD

Plant-Based Diet Linked to Lower Mortality in CKD: ERA 2026

A plant-based dietary pattern was associated with lower all-cause and renal-related mortality in patients with chronic kidney disease.

Antidiabetic Drugs Target Urinary E. coli - EMJ

A prospective cohort study found that maternal diabetics show elevated levels of the inflammation marker C reactive protein.

European Experts Call for Women’s Heart Centres - EMJ

European Experts Unveil Blueprint for Women’s Heart Centres

A new European consensus statement outlined how women’s heart centres could improve diagnosis, treatment, and prevention of cardiovascular disease in females.

White DNA helix on blue background

FDA unveils new plan for genome therapy editing

The guidance allows sponsors to build on data generated from previous R&D programmes.

Finerenone Benefits Non-Diabetic CKD Patients

Finerenone Slows Kidney Function Decline in Non-Diabetic CKD: ERA 2026

Finerenone significantly slowed kidney function decline and reduced cardiovascular-kidney risk in patients with non-diabetic CKD in the FIND-CKD trial.